/EINPresswire.com/ -- VANCOUVER, BC--(Marketwired - February 07, 2017) - LexaGene Holdings Inc. (TSX VENTURE: LXG) (the "Company"). LexaGene is pleased to announce the launch of its new website www.lexagene.com. The website consolidates information already in the public domain.

The Company would also like to announce that LexaGene's CEO, Dr. Jack Regan, will be presenting at the BIO CEO and Investor Conference on February 14^th, at 9:30 AM EST. For those interested in viewing the presentation online, please log on at http://www.veracast.com/webcasts/bio/ceoinvestor2017/17207503237.cfm. If you are unable to view the event as it is broadcast live, the same URL can be used to view an archived version, as long as it is more than 1 hr after the conclusion of the presentation.

In addition, we are on track to complete the first prototype of the Company's pathogen detection system in November 2017. The completion of the alpha prototype is expected to be the first of three phases in the Company's product development plan, which also includes completing a beta prototype and then completing a production unit for commercialization. The exact date of completion is dependent on factors including the timing of third party service providers and availability of capital.

Lastly, the board of directors has adopted a Code of Conduct for the company, which is posted to the website.

ON BEHALF OF THE BOARD "Jack Regan"

Jack Regan, Chief Executive Officer and Director

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors -- including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.